Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World

被引：0
|
作者：
Chen, C. [1 ]
机构：
[1] Zunyi Med Univ, Affiliated Hosp, Zunyi, Guizhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer; Neoadjuvant therapy; PD-1; inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-24
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [41] Perioperative immune checkpoint blockades improve prognosis of resectable non-small cell lung cancer
    Tian, Yu
    Liu, Zhichao
    Pan, Hanbo
    Zhu, Hongda
    Zou, Ningyuan
    Jiang, Long
    Li, Ziming
    Huang, Jia
    Hu, Yingjie
    Luo, Qingquan
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (04)
  • [42] Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer
    Kawachi, Hayato
    Yamada, Tadaaki
    Tamiya, Motohiro
    Negi, Yoshiki
    Goto, Yasuhiro
    Nakao, Akira
    Shiotsu, Shinsuke
    Tanimura, Keiko
    Takeda, Takayuki
    Okada, Asuka
    Harada, Taishi
    Date, Koji
    Chihara, Yusuke
    Hasegawa, Isao
    Tamiya, Nobuyo
    Ishida, Masaki
    Katayama, Yuki
    Morimoto, Kenji
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Kijima, Takashi
    Takayama, Koichi
    JAMA NETWORK OPEN, 2023, 6 (07) : e2322915
  • [43] Neoadjuvant therapy in resectable non-stage IV non-small cell lung cancer: real-world analysis
    Ay, L.
    Fabikan, H.
    Steiner, D.
    Illini, O.
    Krenbek, D.
    Klikovits, T.
    Lang-Stoeberl, A.
    Mueser, N.
    Kirchbacher, K.
    Funk, G. C.
    Watzka, S.
    Valipour, A.
    Hochmair, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S533 - S533
  • [44] Comprehensive Analysis of Immune Responses to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer
    Liu, Weiran
    Chen, Chen
    Li, Chenguang
    Wu, Xinyi
    Ma, Yuchen
    Xie, Jiping
    Wang, Dingli
    Xu, Fei
    Zheng, Xue
    Zhang, Zhenfa
    Wang, Changli
    Yue, Dongsheng
    Zhang, Bin
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (13) : 9332 - 9343
  • [45] Molecular characterization of resistance to immune checkpoint inhibitor and chemotherapy treatment in advanced non-small cell lung cancer
    Kardos, Jordan
    Correa, Paola
    Kim, Sam
    Wang, Min
    Pan, Yang
    Li, Li
    Patterson, Scott Donald
    Iqbal, Shahed
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy
    Inomata, Minehiko
    Minatoyama, Shuhei
    Takata, Naoki
    Hayashi, Kana
    Hirai, Takahiro
    Seto, Zenta
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Matsuyama, Kei
    Hayashi, Ryuji
    Matusi, Shoko
    Tobe, Kazuyuki
    ANTICANCER RESEARCH, 2024, 44 (03) : 1241 - 1245
  • [47] Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer
    Shen, Jie
    Gu, Linping
    Qi, Yuwen
    Yao, Yaxian
    Lu, Shun
    Chen, Zhiwei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    Current Treatment Options in Oncology, 2021, 22
  • [49] Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
    Broderick, Stephen R.
    Bott, Matthew J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (05): : 1471 - 1474
  • [50] Intensity of neoadjuvant therapy in resectable non-small cell lung cancer
    Green, MR
    Barkley, JE
    LUNG CANCER, 1997, 17 : S111 - S119
12345